Showing 7651-7660 of 8826 results for "".
- COVID-19 By the Numbers: May 5 Editionhttps://practicaldermatology.com/news/covid-19-by-the-numbers-may-5-edition/2460375/Sixteen states have significantly reduced COVID-19 restrictions, while 18 have somewhat reduced restrictions, a new analysis from WalletHub reveals. The easing comes as the US reports nearly 70,000 COVI
- Suneva to Distribute Sinclair Pharma's Silhouette Instalift Sutureshttps://practicaldermatology.com/news/suneva-to-distribute-sinclair-pharmas-silhouette-instalift-sutures/2460372/Suneva Medical, Inc. is the exclusive North American distributor for Sinclair Pharma's Silhouette Instalift sutures "We are excited to welcome Silhouette Instalift to our already broad regenerative aesthetics portfolio,"
- Med Spas May Need a Post-COVID-19 Facelifthttps://practicaldermatology.com/news/medspas-may-need-a-post-covid-19-facelift/2460370/Everyone is feeling anxious about returning to public spaces including spas following the COVID-19 pandemic, according to the new ISPA Consumer Snapshot Initiative. “We know that COVID-19 has created a lot of uncertainty in many industries, including the spa industry,” says
- Prescriber’s Choice Launches “PC Direct” and “PC Delivers”https://practicaldermatology.com/news/prescribers-choice-launches-pc-direct-and-pc-delivers/2460362/Two new options from Prescriber’s Choice enable physicians to prescribe and ship medicines directly to patients for the treatment of dozens of dermatologic conditions. The ability to ship Prescriber’s Choice medicines to patients is an alternative to existing in-office dispensing to s
- R2 Technologies Receives $10M Second Tranche Investment for CryoAesthetic Technologyhttps://practicaldermatology.com/news/r2-technologies-receives-10m-second-tranche-investment-for-cryoaesthetic-technology/2460361/R2 Technologies Inc. scored $10 million in funding from Huadong Medicine Company Limited to help to commercialize their CryoAesthetic technology, which reduces the appearance of sun damage and uneven skin tone. The CryoAesthetic procedure
- MD Survey: Telehealth Booming, Prescribing Habits Changing During Pandemichttps://practicaldermatology.com/news/md-survey-telehealth-booming-prescribing-habits-changing-during-pandemic/2460360/More than four-fifths of physicians saw fewer patients in late March, averaging 40 patients per week vs. 103 per week prior to March 2020, according to a new survey of 500 U.S physicians by AbelsonTaylor, a health and wellness marketing agency. What’s more, three-quarters of physi
- Coping with COVID-19: Tips and Tools for Enhancing Virtual Skin Cancer Examshttps://practicaldermatology.com/news/coping-with-covid-19-tips-and-tools-for-enhancing-virtual-skin-cancer-exams-1/2460356/Dermatologists across the country have shut their doors due to the coronavirus pandemic, and little certainty remains about when they will reopen for business as usual. Many are still seeing patients with aggressive squamous cell carcinoma or melanoma, but these patients need to be effectively tr
- Industry Responds to COVID-19: UCB, Galderma, Timeless Skin Carehttps://practicaldermatology.com/news/industry-responds-to-covid-19-ucb-galderma-timeless-skin-care/2460354/UCB. UCB is working with the Seattle Structural Genomics Center for Infectious Disease to identify crystal structures of SARS-CoV-2 proteins. In addition to provi
- Kubota Vision, LEO Pharma A/S to Screen Novel VAP-1 Inhibitors for Inflammatory Skin Diseaseshttps://practicaldermatology.com/news/kubota-vision-leo-pharma-as-to-screen-novel-vap-1-inhibitors-for-inflammatory-skin-diseases/2460351/Kubota Vision Inc. signed an Open Innovation Agreement with LEO Pharma A/S to screen novel Vascular Adhesion Protein-1 (VAP-1) inhibitor compounds for potential therapeutic use in inflammatory skin diseases, such as psoriasis and atopic dermatitis. During R&D activities to develop n
- San Diego Dermatology Symposium Reschedules to Septemberhttps://practicaldermatology.com/news/san-diego-dermatology-symposium-reschedules-to-september/2460350/San Diego Dermatology Symposium will be held September 11-13, 2020, a shift from its original date. "The safety of our attendees, faculty, and exhibitors is our utmost priority, and we have been closely monitoring guidance from federal, state and local governments, as well as the World Healt